NSETrading Window25 Jun 2026 · 25 Jun 2026, 02:21 pm
Trading Window
Shilpa Medicare Limited · SHILPAMED
✦ AI Summary
Shilpa Medicare Limited has informed the Exchange regarding the closure of the trading window for its designated persons and their relatives due to the upcoming declaration of unaudited financial results for the quarter ended 30 June 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Shilpa Medicare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Attachments (1)
📄pdf
Download →
SHILPAMED_25062026142053_Trading_window_notice.pdf
View document text
Shilpa Medicare Limited
Corporate & Admin Office:
“Shilpa House”, # 12-6-214/A-1, Hyderabad Road,
Raichur – 584 135, Karnataka, India
Tel: +91-8532-238704, Fax: +91-8532-238876
Email: info@vbshilpa.com, Web: www.vbshilpa.com
CIN: L85110KA1987PLC008739
Date: 25 June 2026
To To
Corporate Relationship Department National Stock Exchange of India Limited
BSE Limited, Exchange Plaza, 5th Floor,
1st Floor, Rotunda Building, Plot No.C/1, G Block
P.J. Towers, Dalal Street, Bandra Kurla Complex, Bandra (E)
Mumbai – 400 001. Mumbai – 400 051.
Stock Code: BSE – 53054/ NSE – SHILPAMED
Dear Sir/Ma’am,
Sub: Intimation of Closure of Trading Window
Pursuant to the Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing
in the securities of the Company shall remain closed for all the designated persons and their
immediate relatives, Connected Persons (including their relatives) as covered under the said Code
with effect from 01 July 2026, till 48 hours after the declaration of un-audited Financial Results for
quarter ended 30 June 2026.
Accordingly, all Designated Persons of the Company are advised not to trade in the securities of the
Company during the aforesaid period of closure of the Trading Window.
Please note that the date of the Board Meeting to be held for consideration of unaudited Financial
Results of the Company for the quarter ended 30 June 2026, shall be communicated in due course.
This is for your information and records.
Thanking you,
For Shilpa Medicare Limited
Ritu Tiwary
Company Secretary & Compliance Officer